MRSN logo

Mersana Therapeutics (MRSN) Long Term Liabilities

Annual Total Long Term Liabilities

$125.52 M
-$25.23 M-16.74%

December 31, 2023


Summary


Performance

MRSN Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRSNbalance sheetmetrics:

Quarterly Long Term Liabilities

$100.18 M
-$8.34 M-7.68%

September 30, 2024


Summary


Performance

MRSN Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRSNbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

MRSN Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-16.7%-29.8%
3 y3 years+719.9%-29.8%
5 y5 years+10000.0%-29.8%

MRSN Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.7%+240.7%-33.5%+171.9%
5 y5-year-16.7%+2335.8%-33.5%+1844.1%
alltimeall time-16.7%>+9999.0%-33.5%>+9999.0%

Mersana Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$100.18 M(-7.7%)
Jun 2024
-
$108.52 M(-7.2%)
Mar 2024
-
$116.98 M(-6.8%)
Dec 2023
$125.52 M(-16.7%)
$125.52 M(-12.1%)
Sep 2023
-
$142.78 M(-2.4%)
Jun 2023
-
$146.28 M(-1.5%)
Mar 2023
-
$148.50 M(-1.5%)
Dec 2022
$150.75 M(+309.1%)
$150.75 M(+11.0%)
Sep 2022
-
$135.83 M(+189.9%)
Jun 2022
-
$46.85 M(-23.6%)
Mar 2022
-
$61.28 M(+66.3%)
Dec 2021
$36.85 M(+140.7%)
$36.85 M(+104.5%)
Sep 2021
-
$18.02 M(+1.8%)
Jun 2021
-
$17.70 M(+17.6%)
Mar 2021
-
$15.05 M(-1.7%)
Dec 2020
$15.31 M
$15.31 M(-2.8%)
DateAnnualQuarterly
Sep 2020
-
$15.75 M(+8.4%)
Jun 2020
-
$14.53 M(-4.9%)
Mar 2020
-
$15.28 M(+196.5%)
Dec 2019
$5.15 M(+1727.3%)
$5.15 M(-17.2%)
Sep 2019
-
$6.23 M(-10.4%)
Jun 2019
-
$6.95 M(+155.5%)
Mar 2019
-
$2.72 M(+864.9%)
Dec 2018
$282.00 K(-99.0%)
$282.00 K(-99.1%)
Sep 2018
-
$33.08 M(+12.8%)
Jun 2018
-
$29.34 M(-1.8%)
Mar 2018
-
$29.87 M(+3.6%)
Dec 2017
$28.84 M(-78.2%)
$28.84 M(-17.0%)
Sep 2017
-
$34.76 M(-72.3%)
Jun 2017
-
$125.44 M(+305.1%)
Mar 2017
-
$30.97 M(-76.6%)
Dec 2016
$132.32 M(+185.4%)
$132.32 M
Dec 2015
$46.37 M
-

FAQ

  • What is Mersana Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Mersana Therapeutics?
  • What is Mersana Therapeutics annual total long term liabilities year-on-year change?
  • What is Mersana Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Mersana Therapeutics?
  • What is Mersana Therapeutics quarterly long term liabilities year-on-year change?

What is Mersana Therapeutics annual total long term liabilities?

The current annual total long term liabilities of MRSN is $125.52 M

What is the all time high annual total long term liabilities for Mersana Therapeutics?

Mersana Therapeutics all-time high annual total long term liabilities is $150.75 M

What is Mersana Therapeutics annual total long term liabilities year-on-year change?

Over the past year, MRSN annual total long term liabilities has changed by -$25.23 M (-16.74%)

What is Mersana Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of MRSN is $100.18 M

What is the all time high quarterly long term liabilities for Mersana Therapeutics?

Mersana Therapeutics all-time high quarterly total long term liabilities is $150.75 M

What is Mersana Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, MRSN quarterly total long term liabilities has changed by -$42.60 M (-29.83%)